Berlin - Delayed Quote EUR
UroGen Pharma Ltd. R (UR8.BE)
10.00
-0.20
(-1.96%)
As of 10:10:10 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-96,766
-96,766
-76,376
-87,559
-84,892
Investing Cash Flow
-20,613
-20,613
-953
1,060
4,069
Financing Cash Flow
194,619
194,619
116,931
97,134
72,319
End Cash Position
173,063
173,063
95,823
56,221
45,586
Capital Expenditure
-295
-295
-194
-254
-752
Issuance of Capital Stock
151,169
151,169
67,358
--
--
Issuance of Debt
24,488
24,488
--
95,783
--
Free Cash Flow
-97,061
-97,061
-76,570
-87,813
-85,644
12/31/2021 - 2/20/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
I9SA.F Verona Pharma plc
62.60
+0.64%
GON.F Geron Corporation
1.1860
-2.79%
ZH6.BE Biohaven Ltd. R
20.20
0.00%
49BA.BE BeiGene Ltd
222.00
0.00%
PTCT PTC Therapeutics, Inc.
49.95
+0.87%
NUVB Nuvation Bio Inc.
2.4600
+8.37%
ALLO Allogene Therapeutics, Inc.
1.7000
+0.59%
SLS SELLAS Life Sciences Group, Inc.
1.7400
+7.41%
BHVN Biohaven Ltd.
22.85
+1.78%
VRNA Verona Pharma plc
72.73
+0.65%